Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome. [electronic resource]
- British journal of haematology Apr 2004
- 187-95 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0007-1048
10.1111/j.1365-2141.2004.04899.x doi
Adult Aged Antineoplastic Agents--therapeutic use Benzamides Chromosomes, Human--genetics Follow-Up Studies Humans Imatinib Mesylate Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy Middle Aged Piperazines--therapeutic use Pyrimidines--therapeutic use Translocation, Genetic Treatment Outcome